Forteris Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Forteris Wealth Management's BMY Position: Q2 2026 in Review
Forteris Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 22% in Q2 2026, selling an estimated $86.1K and leaving 5,360 shares worth $309K. The position accounts for 0.25% of the portfolio, ranked #61.
Forteris Wealth Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $631K in Q4 2025. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Forteris Wealth Management held 5,360 shares of Bristol-Myers Squibb worth $309K as of Q2 2026.
- Forteris Wealth Management sold 1,500 Bristol-Myers Squibb shares in Q2 2026, an estimated $86.1K.
- Bristol-Myers Squibb made up 0.25% of Forteris Wealth Management's portfolio in Q2 2026, its #61 holding.
- Forteris Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Forteris Wealth Management's Bristol-Myers Squibb position peaked at $631K in Q4 2025.
- 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Forteris Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.